Form 4 Filing for POST LEONARD E

On October 15, 2026, POST LEONARD E, a director at CG Oncology, Inc., reported several transactions. They acquired 1000 shares of Common Stock at a price of $0.6 per share. Concurrently, they disposed of 500 shares of Common Stock at a weighted average price ranging from $61.16 to $62.06, and another 500 shares at a weighted average price ranging from $62.27 to $62.60. These sales were executed under a Rule 10b5-1 trading plan. Additionally, a vested Director Stock Option (right to buy) for 1000 shares was exercised, with an exercise price of $0.6. Following these transactions, the post-transaction shares for Common Stock are 0, and the post-transaction shares for the stock option are 102,077.